Nothing Special   »   [go: up one dir, main page]

CN110551076A - benzoxazole liquid crystal compound containing acetylene bonds and preparation method thereof - Google Patents

benzoxazole liquid crystal compound containing acetylene bonds and preparation method thereof Download PDF

Info

Publication number
CN110551076A
CN110551076A CN201910813705.8A CN201910813705A CN110551076A CN 110551076 A CN110551076 A CN 110551076A CN 201910813705 A CN201910813705 A CN 201910813705A CN 110551076 A CN110551076 A CN 110551076A
Authority
CN
China
Prior art keywords
phenyl
liquid crystal
alkoxy
ethynyl
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910813705.8A
Other languages
Chinese (zh)
Inventor
陈新兵
任丽媛
张梦婷
刘国庆
陈沛
安忠维
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shaanxi Normal University
Original Assignee
Shaanxi Normal University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shaanxi Normal University filed Critical Shaanxi Normal University
Priority to CN201910813705.8A priority Critical patent/CN110551076A/en
Publication of CN110551076A publication Critical patent/CN110551076A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D263/57Aryl or substituted aryl radicals
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

本发明公开了一种含炔键的苯并噁唑液晶化合物及其制备方法,属于材料技术领域。该化合物的结构式为式中R代表C5~C12的直链烷基,X代表氢、甲基或硝基。该化合物以对溴苯甲醛、2‑甲基‑3‑丁炔‑2‑醇、1‑碘‑4‑(烷氧基)苯、氨基酚为原料,通过Sonogashira偶联、亲核加成、关环等反应。本发明液晶化合物具有大双折射率和宽的液晶相区,可应用于液晶光电器件中,以提高其响应速度。

The invention discloses an acetylene bond-containing benzoxazole liquid crystal compound and a preparation method thereof, belonging to the technical field of materials. The structural formula of this compound is In the formula, R represents a C 5 -C 12 straight-chain alkyl group, and X represents hydrogen, methyl or nitro. The compound uses p-bromobenzaldehyde, 2-methyl-3-butyne-2-alcohol, 1-iodo-4-(alkoxy)benzene and aminophenol as raw materials, and is subjected to Sonogashira coupling, nucleophilic addition, Ring closure and other reactions. The liquid crystal compound of the present invention has large birefringence and wide liquid crystal phase region, and can be used in liquid crystal optoelectronic devices to improve its response speed.

Description

含炔键的苯并噁唑液晶化合物及其制备方法Alkyne bond-containing benzoxazole liquid crystal compound and preparation method thereof

技术领域technical field

本发明属于材料技术领域,具体涉及含炔键的苯并噁唑液晶化合物及其制备方法。The invention belongs to the technical field of materials, and particularly relates to an acetylene bond-containing benzoxazole liquid crystal compound and a preparation method thereof.

背景技术Background technique

液晶材料广泛应用于平板电脑、手机、笔记本电脑和高清电视等显示领域,以及光调制器、激光光束偏转、自适应光学等非显示领域。液晶光电器件具有驱动电压低、相位调制量大、重量轻、功耗低等优点。Liquid crystal materials are widely used in display fields such as tablet computers, mobile phones, notebook computers and high-definition TVs, as well as non-display fields such as light modulators, laser beam deflection, and adaptive optics. Liquid crystal optoelectronic devices have the advantages of low driving voltage, large amount of phase modulation, light weight, and low power consumption.

液晶材料是液晶光电器件的关键核心材料,而液晶光电器件的性能优化主要是通过调控液晶材料的结构和组分来实现。近年来,快速响应是液晶光电器件一直追求的重要发展方向。为了提高液晶光电器件的响应速度,一方面可以采用低粘度的液晶化合物,液晶化合物的粘度与液晶器件的响应时间有直接关系,即液晶材料的粘度越低,液晶器件的响应时间越小、响应速度越快;另一方面可以降低液晶器件盒厚,液晶器件盒厚越低,响应速度越快,而使用大光学各向异性(Δn)液晶材料能够在实际应用中有效减小液晶器件盒厚。因而大Δn液晶是液晶光电器件实现快速响应的关键材料。Liquid crystal materials are the key core materials of liquid crystal optoelectronic devices, and the performance optimization of liquid crystal optoelectronic devices is mainly achieved by adjusting the structure and composition of liquid crystal materials. In recent years, fast response has been an important development direction of liquid crystal optoelectronic devices. In order to improve the response speed of liquid crystal optoelectronic devices, on the one hand, low-viscosity liquid crystal compounds can be used. The viscosity of liquid crystal compounds is directly related to the response time of liquid crystal devices. The faster the speed; on the other hand, the cell thickness of the liquid crystal device can be reduced. The lower the cell thickness of the liquid crystal device, the faster the response speed, and the use of large optical anisotropy (Δn) liquid crystal material can effectively reduce the cell thickness of the liquid crystal device in practical applications. . Therefore, large Δn liquid crystal is the key material for realizing fast response of liquid crystal optoelectronic devices.

液晶化合物结构一般由苯环、环己基、芳杂环等作为刚性骨架构建,可以通过引入炔键、增加苯环、引入氰基或异硫氰基等增加液晶分子共轭长度,进而提升液晶化合物的Δn。目前虽然有不少光学各向异性液晶材料,但是其Δn不够大、种类不够多,限制了其在液晶光电器件中的应用。尤其可作为液晶光电器件使用的大Δn芳杂环类液晶化合物种类非常少。The structure of liquid crystal compounds is generally constructed of benzene ring, cyclohexyl, aromatic heterocycle, etc. as a rigid skeleton. It can increase the conjugation length of liquid crystal molecules by introducing alkyne bonds, adding benzene rings, introducing cyano groups or isothiocyanato groups, etc., and then improving the liquid crystal compounds. Δn. Although there are many optically anisotropic liquid crystal materials at present, their Δn is not large enough and there are not enough types, which limits their application in liquid crystal optoelectronic devices. In particular, there are very few kinds of large Δn aromatic heterocyclic liquid crystal compounds that can be used as liquid crystal optoelectronic devices.

发明内容SUMMARY OF THE INVENTION

本发明的目的是提供一种具有大双折射率的含炔键的苯并噁唑液晶化合物,并为该化合物提供一种工艺步骤简单、收率高的制备方法。The purpose of the present invention is to provide a benzoxazole liquid crystal compound containing an acetylene bond with a large birefringence, and to provide a preparation method for the compound with simple process steps and high yield.

针对上述目的,本发明所采用的含炔键的苯并噁唑液晶化合物的结构式如下:For the above purpose, the structural formula of the acetylenic bond-containing benzoxazole liquid crystal compound used in the present invention is as follows:

式中R代表C5~C12的直链烷基,X代表H、CH3、NO2中任意一种。In the formula, R represents a C 5 -C 12 straight-chain alkyl group, and X represents any one of H, CH 3 and NO 2 .

上述含炔键的苯并噁唑液晶化合物的制备方法由下述步骤组成:The preparation method of the above-mentioned acetylenic bond-containing benzoxazole liquid crystal compound consists of the following steps:

1、制备4-(4-(1,3-二氧戊环-2-基)苯基)-2-甲基丁-3-炔-2-醇1. Preparation of 4-(4-(1,3-dioxolan-2-yl)phenyl)-2-methylbut-3-yn-2-ol

将对溴苯甲醛、对甲苯磺酸、乙二醇加入三氯甲烷中,在50~70℃反应6~8h,减压蒸除溶剂,然后在氮气保护下,加入2-甲基-3-丁炔-2-醇、碘化亚铜、三苯基膦、四(三苯基膦)钯、三乙胺,在80~90℃下反应8~10h,分离纯化,得到4-(4-(1,3-二氧戊环-2-基)苯基)-2-甲基丁-3-炔-2-醇,反应方程式如下:Add p-bromobenzaldehyde, p-toluenesulfonic acid and ethylene glycol to chloroform, react at 50-70°C for 6-8 hours, evaporate the solvent under reduced pressure, and then add 2-methyl-3- Butyn-2-ol, cuprous iodide, triphenylphosphine, tetrakis (triphenylphosphine) palladium, triethylamine, react at 80~90℃ for 8~10h, separate and purify to obtain 4-(4- (1,3-dioxolane-2-yl)phenyl)-2-methylbut-3-yn-2-ol, the reaction equation is as follows:

2、制备2-(4-((4-(烷氧基)苯基)乙炔基)苯基)-1,3-二氧戊环2. Preparation of 2-(4-((4-(alkoxy)phenyl)ethynyl)phenyl)-1,3-dioxolane

将4-(4-(1,3-二氧戊环-2-基)苯基)-2-甲基丁-3-炔-2-醇、式I所示1-碘-4-(烷氧基)苯、乙二醇乙醚、氢氧化钠、四(三苯基膦)钯加入甲苯中,在氮气保护下60~80℃反应8~10h,反应结束后,分离纯化,得到2-(4-((4-(烷氧基)苯基)乙炔基)苯基)-1,3-二氧戊环,反应方程式如下:4-(4-(1,3-dioxolan-2-yl)phenyl)-2-methylbut-3-yn-2-ol, 1-iodo-4-(alkane shown in formula I Oxy)benzene, ethylene glycol ether, sodium hydroxide, and tetrakis(triphenylphosphine)palladium were added to toluene, and reacted at 60-80 °C for 8-10 h under nitrogen protection. After the reaction was completed, separation and purification were performed to obtain 2-( 4-((4-(alkoxy)phenyl)ethynyl)phenyl)-1,3-dioxolane, the reaction equation is as follows:

式I中,R代表C5~C12的直链烷基。In formula I, R represents a C 5 -C 12 straight-chain alkyl group.

3、制备4-((4-(烷氧基)苯基)乙炔基)苯甲醛3. Preparation of 4-((4-(alkoxy)phenyl)ethynyl)benzaldehyde

将4-((4-(烷氧基)苯基)乙炔基)苯基)-1,3-二氧戊环、甲酸加入四氢呋喃中,在50~70℃下反应5~6h,反应结束后,分离纯化,得到4-((4-(烷氧基)苯基)乙炔基)苯甲醛,反应方程式如下:Add 4-((4-(alkoxy)phenyl)ethynyl)phenyl)-1,3-dioxolane and formic acid to tetrahydrofuran, and react at 50~70℃ for 5~6h, after the reaction is over , separation and purification to obtain 4-((4-(alkoxy) phenyl) ethynyl) benzaldehyde, the reaction equation is as follows:

4、制备2-((4-((4-(烷氧基)苯基)乙炔基)苯亚甲基)氨基)苯酚4. Preparation of 2-((4-((4-(alkoxy)phenyl)ethynyl)benzylidene)amino)phenol

将4-((4-(烷氧基)苯基)乙炔基)苯甲醛、式II所示氨基酚加入乙醇中,搅拌回流4~6h,减压蒸馏除去溶剂,重结晶得到2-((4-((4-(烷氧基)苯基)乙炔基)苯亚甲基)氨基)苯酚,反应方程式如下:Add 4-((4-(alkoxy)phenyl)ethynyl)benzaldehyde and aminophenol shown in formula II to ethanol, stir and reflux for 4-6h, remove the solvent by vacuum distillation, and recrystallize to obtain 2-(( 4-((4-(alkoxy) phenyl) ethynyl) benzylidene) amino) phenol, reaction equation is as follows:

式II中,X代表H、CH3、NO2中任意一种。In formula II, X represents any one of H, CH 3 and NO 2 .

5、制备含炔键的苯并噁唑液晶化合物5. Preparation of acetylene bond-containing benzoxazole liquid crystal compounds

将2-((4-((4-(烷氧基)苯基)乙炔基)苯亚甲基)氨基)苯酚、二氯二氰基苯醌(DDQ)加入三氯甲烷中,回流反应4~6h后,停止反应,分离纯化,得到目标化合物——含炔键的苯并噁唑液晶化合物,反应方程式如下:Add 2-((4-((4-(alkoxy)phenyl)ethynyl)benzylidene)amino)phenol and dichlorodicyanobenzoquinone (DDQ) to chloroform, reflux reaction 4 After ~6h, stop the reaction, separate and purify, and obtain the target compound - a benzoxazole liquid crystal compound containing an alkyne bond. The reaction equation is as follows:

上述步骤1中,优选对溴苯甲醛与对甲苯磺酸、乙二醇的摩尔比4:0.9~1.2:80~90,对溴苯甲醛与2-甲基-3-丁炔-2-醇、碘化亚铜、三苯基膦、四(三苯基膦)钯的摩尔比1:0.4~1:0.01~0.03:0.04~0.08:0.007~0.01。In the above step 1, the molar ratio of p-bromobenzaldehyde to p-toluenesulfonic acid and ethylene glycol is preferably 4:0.9~1.2:80~90, p-bromobenzaldehyde to 2-methyl-3-butyn-2-ol , the molar ratio of cuprous iodide, triphenylphosphine and tetrakis(triphenylphosphine) palladium is 1:0.4-1:0.01-0.03:0.04-0.08:0.007-0.01.

上述步骤2中,优选4-(4-(1,3-二氧戊环-2-基)苯基)-2-甲基丁-3-炔-2-醇与1-碘-4-(烷氧基)苯、乙二醇乙醚、氢氧化钠、四(三苯基膦)钯的摩尔比1:1~1.2:10~15:5~8:0.02~0.05。In the above step 2, preferably 4-(4-(1,3-dioxolane-2-yl)phenyl)-2-methylbut-3-yn-2-ol and 1-iodo-4-( The molar ratio of alkoxy)benzene, ethylene glycol ether, sodium hydroxide, and tetrakis(triphenylphosphine)palladium is 1:1-1.2:10-15:5-8:0.02-0.05.

上述步骤3中,优选2-(4-((4-(己氧基)苯基)乙炔基)苯基)-1,3-二氧戊环与甲酸的摩尔比为1:180~185。In the above step 3, the molar ratio of 2-(4-((4-(hexyloxy)phenyl)ethynyl)phenyl)-1,3-dioxolane to formic acid is preferably 1:180-185.

上述步骤4中,优选4-((4-(烷氧基)苯基)乙炔基)苯甲醛与氨基酚的摩尔比1:1.1~1.5。In the above step 4, the molar ratio of 4-((4-(alkoxy)phenyl)ethynyl)benzaldehyde to aminophenol is preferably 1:1.1-1.5.

上述步骤5中,优选2-((4-((4-(烷氧基)苯基)乙炔基)苯亚甲基)氨基)苯酚与二氯二氰基苯醌的摩尔比为1:1.1~1.5。In the above-mentioned steps 5, the preferred mol ratio of 2-((4-((4-(alkoxy)phenyl)ethynyl)benzylidene)amino)phenol to dichlorodicyanoquinone is 1:1.1 ~1.5.

本发明的有益效果如下:The beneficial effects of the present invention are as follows:

本发明液晶化合物是以对溴苯甲醛、2-甲基-3-丁炔-2-醇、1-碘-4-(烷氧基)苯、氨基酚为原料,通过Sonogashira偶联、亲核加成、关环等反应制备而成,其既具有杂环液晶介晶相类型,又具有较大的双折射率,同时具有宽的向列相区间,且其制备方法步骤简单、收率高,可应用于液晶光电器件中,以提高其响应速度。The liquid crystal compound of the present invention uses p-bromobenzaldehyde, 2-methyl-3-butyn-2-ol, 1-iodo-4-(alkoxy)benzene and aminophenol as raw materials, and is coupled through Sonogashira and nucleophilic. It is prepared by reactions such as addition and ring closure. It not only has the heterocyclic liquid crystal mesogenic phase type, but also has a large birefringence and a wide nematic phase interval, and the preparation method has simple steps and high yield. , which can be used in liquid crystal optoelectronic devices to improve their response speed.

附图说明Description of drawings

图1是实施例1得到的液晶化合物的DSC曲线(升降温速率5℃/min)。1 is a DSC curve of the liquid crystal compound obtained in Example 1 (temperature rise and fall rate of 5° C./min).

图2是实施例1得到的液晶化合物升温至179.2℃时的POM照片(200×)。2 is a POM photograph (200×) of the liquid crystal compound obtained in Example 1 when the temperature was raised to 179.2°C.

图3是实施例1得到的液晶化合物降温至201.8℃时的POM照片(200×)。3 is a POM photograph (200×) of the liquid crystal compound obtained in Example 1 when the temperature was lowered to 201.8°C.

具体实施方式Detailed ways

下面结合附图和实施例对本发明进一步详细说明,但本发明的保护范围不仅限于这些实施例。The present invention is further described in detail below with reference to the accompanying drawings and embodiments, but the protection scope of the present invention is not limited to these embodiments.

实施例1Example 1

1、制备4-(4-(1,3-二氧戊环-2-基)苯基)-2-甲基丁-3-炔-2-醇1. Preparation of 4-(4-(1,3-dioxolan-2-yl)phenyl)-2-methylbut-3-yn-2-ol

在装有冷凝管和搅拌子的250mL三口瓶中加入对溴苯甲醛10g(54mmol)、对甲苯磺酸2.3g(13.4mmol)、乙二醇75g(1203.6mmol),并向其中加入经过分子筛干燥的三氯甲烷100mL,在60℃的恒温油浴锅中搅拌6h后停止反应,减压蒸除溶剂,向其中加入2-甲基-3-丁炔-2-醇2.01g(23.8mmol)、碘化亚铜0.2g(1.0mmol)、三苯基膦0.6g(2.2mmol),并加入80mL三乙胺作为反应溶剂,在80℃的恒温油浴锅中加热并通氮气保护,反应1h后,在氮气保护下迅速加入四(三苯基膦)钯0.5g(0.43mmol),继续反应8h后停止反应。反应结束后,用水稀释反应体系,用二氯甲烷萃取,分出有机相,并用二氯甲烷重复萃取水相,合并有机相,将得到的有机相用饱和氯化铵水溶液洗涤三次,无水硫酸镁干燥,减压蒸馏旋出溶剂,向其中加入7g硅胶制样,柱色谱分离(洗脱剂为石油醚与乙酸乙酯体积比为30:1的混合液),得到黄色油状液体4-(4-(1,3-二氧戊环-2-基)苯基)-2-甲基丁-3-炔-2-醇,收率44%,反应方程式如下:In a 250mL three-necked flask equipped with a condenser tube and a stirrer, add p-bromobenzaldehyde 10g (54mmol), p-toluenesulfonic acid 2.3g (13.4mmol), ethylene glycol 75g (1203.6mmol), and add it to it after drying with molecular sieves 100 mL of chloroform was stirred in a constant temperature oil bath at 60 ° C for 6 h to stop the reaction, the solvent was evaporated under reduced pressure, and 2.01 g (23.8 mmol) of 2-methyl-3-butyn-2-ol, 2.01 g (23.8 mmol), 0.2 g (1.0 mmol) of cuprous iodide, 0.6 g (2.2 mmol) of triphenylphosphine, and 80 mL of triethylamine were added as the reaction solvent, heated in a constant temperature oil bath at 80 °C and protected by nitrogen, and reacted for 1 h after , 0.5 g (0.43 mmol) of tetrakis (triphenylphosphine) palladium was rapidly added under nitrogen protection, and the reaction was stopped after continuing the reaction for 8 h. After the reaction, the reaction system was diluted with water, extracted with dichloromethane, the organic phase was separated, and the aqueous phase was repeatedly extracted with dichloromethane. Magnesium was dried, the solvent was evaporated under reduced pressure, and 7g of silica gel was added to it for sample preparation, and column chromatography was performed (the eluent was a mixture of petroleum ether and ethyl acetate with a volume ratio of 30:1) to obtain a yellow oily liquid 4-( 4-(1,3-dioxolan-2-yl)phenyl)-2-methylbut-3-yn-2-ol, yield 44%, the reaction equation is as follows:

2、制备2-(4-((4-(己氧基)苯基)乙炔基)苯基)-1,3-二氧戊环2. Preparation of 2-(4-((4-(hexyloxy)phenyl)ethynyl)phenyl)-1,3-dioxolane

在装有搅拌子和冷凝管的250mL三口烧瓶中依次加入4-(4-(1,3-二氧戊环-2-基)苯基)-2-甲基丁-3-炔-2-醇2.8g(12mmol)、1-碘-4-(己氧基)苯3.8(12.6mmol)、乙二醇乙醚10.8g(120.5mmol)、氢氧化钠2.9g(72.2mmol)、甲苯80mL,在70℃的恒温油浴锅中加热并通氮气保护,反应1h后,在氮气保护下迅速加入四(三苯基膦)钯0.28g(0.24mmol),继续反应8h后停止反应。反应结束后,用水稀释反应体系,用二氯甲烷萃取,分出有机相,并用二氯甲烷重复萃取水相,合并有机相,将得到的有机相用饱和氯化铵溶液洗涤三次,无水硫酸镁干燥,减压蒸馏旋出溶剂,向其中加入7g硅胶制样,柱色谱分离(洗脱剂为石油醚与乙酸乙酯体积比为30:1的混合液),得到淡黄色固体2-(4-((4-(己氧基)苯基)乙炔基)苯基)-1,3-二氧戊环,收率59%,反应方程式如下:4-(4-(1,3-dioxolan-2-yl)phenyl)-2-methylbut-3-yn-2- Alcohol 2.8g (12mmol), 1-iodo-4-(hexyloxy)benzene 3.8 (12.6mmol), ethylene glycol ether 10.8g (120.5mmol), sodium hydroxide 2.9g (72.2mmol), toluene 80mL, in It was heated in a constant temperature oil bath at 70°C and protected with nitrogen. After 1 h of reaction, 0.28 g (0.24 mmol) of tetrakis(triphenylphosphine) palladium was rapidly added under nitrogen protection, and the reaction was stopped after continuing the reaction for 8 h. After the reaction, the reaction system was diluted with water, extracted with dichloromethane, the organic phase was separated, and the aqueous phase was repeatedly extracted with dichloromethane, the organic phases were combined, and the obtained organic phase was washed three times with saturated ammonium chloride solution, and anhydrous sulfuric acid Magnesium was dried, the solvent was evaporated under reduced pressure, and 7g of silica gel was added to it for sample preparation, and column chromatography was performed (the eluent was a mixture of petroleum ether and ethyl acetate in a volume ratio of 30:1) to obtain a pale yellow solid 2-( 4-((4-(hexyloxy)phenyl)ethynyl)phenyl)-1,3-dioxolane, yield 59%, the reaction equation is as follows:

3、制备4-((4-(己氧基)苯基)乙炔基)苯甲醛3. Preparation of 4-((4-(hexyloxy)phenyl)ethynyl)benzaldehyde

在装有搅拌子和冷凝管的250mL单口烧瓶中依次加入2-(4-((4-(己氧基)苯基)乙炔基)苯基)-1,3-二氧戊环2.5g(7.4mmol)、甲酸62g(1339mmol)、四氢呋喃80mL,在60℃恒温油浴中加热反应6h。反应结束后,用二氯甲烷和水萃取反应液,旋蒸浓缩,得到白色固体,加无水乙醇重结晶,得到白色固体4-((4-(己氧基)苯基)乙炔基)苯甲醛,收率83%,反应方程式如下:2-(4-((4-(hexyloxy)phenyl)ethynyl)phenyl)-1,3-dioxolane 2.5g ( 7.4 mmol), 62 g (1339 mmol) of formic acid, and 80 mL of tetrahydrofuran, heated and reacted in a constant temperature oil bath at 60° C. for 6 h. After the reaction, the reaction solution was extracted with dichloromethane and water, concentrated by rotary evaporation to obtain a white solid, which was recrystallized by adding absolute ethanol to obtain a white solid 4-((4-(hexyloxy)phenyl)ethynyl)benzene Formaldehyde, yield 83%, reaction equation is as follows:

4、制备2-((4-((4-(己氧基)苯基)乙炔基)苯亚甲基)氨基)-4-甲基苯酚4. Preparation of 2-((4-((4-(hexyloxy)phenyl)ethynyl)benzylidene)amino)-4-methylphenol

在装有搅拌子和冷凝管的100mL单口瓶中加入4-((4-(己氧基)苯基)乙炔基)苯甲醛0.4g(1.4mmol)、2-氨基-4-甲基苯酚0.20g(1.6mmol)、无水乙醇40mL,80℃搅拌回流6h至反应完全。冷却到室温,有黄色针状晶体析出,用布氏漏斗抽滤,得到黄色固体2-((4-((4-(己氧基)苯基)乙炔基)苯亚甲基)氨基)-4-甲基苯酚,收率83%,反应方程式如下:In a 100mL single-necked flask equipped with a stirring bar and a condenser tube, add 0.4g (1.4mmol) of 4-((4-(hexyloxy)phenyl)ethynyl)benzaldehyde, 0.20 g (1.4 mmol) of 2-amino-4-methylphenol, g (1.6 mmol), 40 mL of anhydrous ethanol, stirred and refluxed at 80° C. for 6 h until the reaction was complete. After cooling to room temperature, yellow needle crystals were precipitated, which was filtered with a Buchner funnel to obtain a yellow solid 2-((4-((4-(hexyloxy)phenyl)ethynyl)benzylidene)amino)- 4-methylphenol, yield 83%, reaction equation is as follows:

5、制备2-(4-((4-(己氧基)苯基)乙炔基)苯基)-5-甲基苯并噁唑液晶5. Preparation of 2-(4-((4-(hexyloxy)phenyl)ethynyl)phenyl)-5-methylbenzoxazole liquid crystal

在装有搅拌子和冷凝管的100mL单口瓶中加入2-((4-((4-(己氧基)苯基)乙炔基)苯亚甲基)氨基)-4-甲基苯酚0.2g(0.50mmol)、DDQ 0.14g(0.62mmol)、三氯甲烷80mL,采用恒温油浴将其加热至回流,反应5h至反应完全。待反应液冷却到室温时,用二氯甲烷和水萃取反应液,合并有机相,旋除溶剂,加入4g硅胶制样,柱色谱分离(洗脱剂为石油醚与乙酸乙酯体积比为30:1的混合液),得到白色固体2-(4-((4-(己氧基)苯基)乙炔基)苯基)-5-甲基苯并噁唑液晶化合物,收率89%,反应方程式如下:0.2g of 2-((4-((4-(hexyloxy)phenyl)ethynyl)benzylidene)amino)-4-methylphenol was added to a 100mL single-necked flask equipped with a stirring bar and a condenser tube (0.50 mmol), 0.14 g (0.62 mmol) of DDQ, 80 mL of chloroform, heated to reflux with a constant temperature oil bath, and reacted for 5 h until the reaction was complete. When the reaction solution was cooled to room temperature, the reaction solution was extracted with dichloromethane and water, the organic phases were combined, the solvent was removed by rotation, 4 g of silica gel was added for sample preparation, and column chromatography was performed (the eluent was petroleum ether and the volume ratio of ethyl acetate was 30%). : 1 mixture) to obtain a white solid 2-(4-((4-(hexyloxy)phenyl)ethynyl)phenyl)-5-methylbenzoxazole liquid crystal compound with a yield of 89%, The reaction equation is as follows:

产物的波谱数据如下:The spectral data of the product are as follows:

IR(KBr)v(cm-1):2923,2852,2208,1598,1510,1469,1406,1242,1045,833,794.IR(KBr)v(cm -1 ): 2923, 2852, 2208, 1598, 1510, 1469, 1406, 1242, 1045, 833, 794.

1H-NMR(400MHz,CDCl3,TMS)δ(ppm)=8.23-8.16(m,2H),7.66-7.60(m 2H),7.57-7.52(m,1H),7.51-7.45(m,2H),7.45-7.40(d,3JH-H=8.45Hz,1H),7.19-7.12(dd,3JH-H=8.24Hz,4JH-H=1.59Hz 1H),6.93-6.83(m,2H),4.00-3.88(q,3JH-H=6.55Hz,2H),2.48(s,3H),1.89-1.72(m,2H),1.51-1.32(m,6H),1.01-0.88(t,3JH-H=6.68Hz,3H). 1 H-NMR (400MHz, CDCl 3 , TMS) δ (ppm)=8.23-8.16 (m, 2H), 7.66-7.60 (m 2H), 7.57-7.52 (m, 1H), 7.51-7.45 (m, 2H) ), 7.45-7.40 (d, 3 J HH = 8.45Hz, 1H), 7.19-7.12 (dd, 3 J HH = 8.24Hz, 4 J HH = 1.59Hz 1H), 6.93-6.83 (m, 2H), 4.00 -3.88(q, 3 J HH = 6.55Hz, 2H), 2.48(s, 3H), 1.89-1.72(m, 2H), 1.51-1.32(m, 6H), 1.01-0.88(t, 3 J HH = 6.68Hz, 3H).

MS(MALDI-TOF)m/z:理论值409.53,实测值409.22.MS(MALDI-TOF) m/z: theoretical value 409.53, measured value 409.22.

实施例2Example 2

本实施例的步骤4中,用等摩尔邻氨基苯酚替换实施例1步骤4中的2-氨基-4-甲基苯酚,其他步骤与实施例1相同,得到结构式如下的2-(4-((4-(己氧基)苯基)乙炔基)苯基)苯并噁唑,收率89%。In step 4 of the present embodiment, the 2-amino-4-methylphenol in step 4 of embodiment 1 is replaced with equimolar o-aminophenol, and other steps are the same as those of embodiment 1 to obtain the following 2-(4-( (4-(hexyloxy)phenyl)ethynyl)phenyl)benzoxazole, 89% yield.

产物的波谱数据如下:The spectral data of the product are as follows:

IR(KBr)v(cm-1):2927,2852,2208,1598,1510,1458,1280,1240,1174,1049,838.1H-NMR(400MHz,CDCl3,TMS)δ(ppm)=7.99-7.93(m,1H),7.86-7.83(m 1H),7.64-7.60(m,1H),7.53-7.48(m,2H),7.43-7.35(m,3H),6.97-6.83(m,2H),4.07-3.91(q,3JH-H=6.57Hz,2H),1.86-1.72(m,2H),1.51-1.31(m,6H),0.99-0.84(t,3JH-H=6.88Hz,3H).IR(KBr)v(cm -1 ): 2927, 2852, 2208, 1598, 1510, 1458, 1280, 1240, 1174, 1049, 838. 1 H-NMR (400 MHz, CDCl 3 , TMS) δ (ppm)= 7.99-7.93(m, 1H), 7.86-7.83(m 1H), 7.64-7.60(m, 1H), 7.53-7.48(m, 2H), 7.43-7.35(m, 3H), 6.97-6.83(m, 2H), 4.07-3.91(q, 3 J HH =6.57Hz, 2H), 1.86-1.72(m, 2H), 1.51-1.31(m, 6H), 0.99-0.84(t, 3 J HH =6.88Hz, 3H).

MS(MALDI-TOF)m/z:理论值395.5,实测值395.21.MS(MALDI-TOF) m/z: theoretical value 395.5, measured value 395.21.

实施例3Example 3

本实施例的步骤4中,用等摩尔2-氨基-4-硝基苯酚替换实施例1步骤4中的2-氨基-4-甲基苯酚,其他步骤与实施例1相同,得到结构式如下的2-(4-((4-(己氧基)苯基)乙炔基)苯基)-5-硝基苯并噁唑,收率67%。In step 4 of this embodiment, 2-amino-4-methylphenol in step 4 of embodiment 1 is replaced with equimolar 2-amino-4-nitrophenol, and other steps are the same as those of embodiment 1, and the following structural formula is obtained 2-(4-((4-(hexyloxy)phenyl)ethynyl)phenyl)-5-nitrobenzoxazole, yield 67%.

产物的波谱数据如下:The spectral data of the product are as follows:

IR(KBr)v(cm-1):2933,2862,2204,1596,1512,1344,1249,1016,823,738,6.IR(KBr)v(cm -1 ): 2933, 2862, 2204, 1596, 1512, 1344, 1249, 1016, 823, 738, 6.

1H-NMR(400MHz,CDCl3,TMS)δ(ppm)=8.65-8.62(d,J4 H-H=2.44Hz,1H),8.35-8.29(dd,J3 H-H=8.9Hz,J4 H-H=2.26Hz,1H),8.25-8.20(m,2H),7.73-7.63(m,3H),7.50-7.44(m,2H),6.94-6.84(m,2H),4.07-3.94(q,3JH-H=6.83Hz,2H),1.86-1.73(m,2H),1.51-1.32(m,6H),0.99-0.84(t,3JH-H=6.88Hz,3H). 1 H-NMR (400MHz, CDCl 3 , TMS) δ (ppm)=8.65-8.62 (d, J 4 HH =2.44Hz, 1H), 8.35-8.29 (dd, J 3 HH =8.9Hz, J 4 HH = 2.26Hz, 1H), 8.25-8.20(m, 2H), 7.73-7.63(m, 3H), 7.50-7.44(m, 2H), 6.94-6.84(m, 2H), 4.07-3.94(q, 3 J HH = 6.83Hz, 2H), 1.86-1.73 (m, 2H), 1.51-1.32 (m, 6H), 0.99-0.84 (t, 3 J HH = 6.88Hz, 3H).

MS(MALDI-TOF)m/z:理论值440.5,实测值440.23.MS (MALDI-TOF) m/z: theoretical value 440.5, measured value 440.23.

对上述实施例1~3制备的液晶化合物的光学各向异性和热性能进行测试,得到其双折射率、相转变温度和相变焓。双折射率是通过Gaussian09软件得到理论值;也可以通过阿贝折光仪测试得到实验值;相转变温度和相变焓是通过差示扫描量热仪测试得出。结果见表1和表2。The optical anisotropy and thermal properties of the liquid crystal compounds prepared in the above examples 1 to 3 were tested to obtain their birefringence, phase transition temperature and phase transition enthalpy. The theoretical value of birefringence is obtained by Gaussian09 software; the experimental value can also be obtained by Abbe refractometer test; the phase transition temperature and phase transition enthalpy are obtained by differential scanning calorimeter test. The results are shown in Tables 1 and 2.

表1双折射率Table 1 Birefringence

表2相转变温度和相变焓Table 2 Phase transition temperature and phase transition enthalpy

注:表中Cr代表结晶相;N代表向列相;I代表各向同性。Note: Cr in the table represents crystalline phase; N represents nematic phase; I represents isotropic phase.

由表1和表2可见,本发明液晶化合物(实验值Δn≥0.623)与文献(LiquidCrystals,2017,44:14-15,2184-2191)中大双折射率液晶化合物(测试值Δn=0.305)相比,Δn显著提高,进一步证明本发明液晶化合物具有优异的光学各向异性。It can be seen from Table 1 and Table 2 that the liquid crystal compound of the present invention (experimental value Δn≥0.623) and the large birefringence liquid crystal compound in the literature (Liquid Crystals, 2017, 44: 14-15, 2184-2191) (test value Δn=0.305), Δn is significantly improved, which further proves that the liquid crystal compound of the present invention has excellent optical anisotropy.

由表2可见,本发明液晶化合物均具有较宽的向列相区间。It can be seen from Table 2 that the liquid crystal compounds of the present invention all have a wide nematic phase interval.

图1的DSC曲线(升降温速率5℃/min)及图2和3的POM照片(200×)可见,本发明化合物具有向列相的液晶织构及在升降温中均具有液晶相态。It can be seen from the DSC curve of Fig. 1 (temperature rise and fall rate of 5°C/min) and the POM photographs (200×) of Figs.

Claims (7)

1.一种含炔键的苯并噁唑液晶化合物,其特征在于该化合物的结构式如下:1. a benzoxazole liquid crystal compound containing an alkyne bond, is characterized in that the structural formula of this compound is as follows: 式中R代表C5~C12的直链烷基,X代表H、CH3、NO2中任意一种。In the formula, R represents a C 5 -C 12 straight-chain alkyl group, and X represents any one of H, CH 3 and NO 2 . 2.一种权利要求1所述的含炔键的苯并噁唑液晶化合物的制备方法,其特征在于它由下述步骤组成:2. the preparation method of the benzoxazole liquid crystal compound containing an acetylenic bond according to claim 1, is characterized in that it is made up of the following steps: (1)制备4-(4-(1,3-二氧戊环-2-基)苯基)-2-甲基丁-3-炔-2-醇(1) Preparation of 4-(4-(1,3-dioxolan-2-yl)phenyl)-2-methylbut-3-yn-2-ol 将对溴苯甲醛、对甲苯磺酸、乙二醇加入三氯甲烷中,在50~70℃反应6~8h,减压蒸除溶剂,然后在氮气保护下,加入2-甲基-3-丁炔-2-醇、碘化亚铜、三苯基膦、四(三苯基膦)钯、三乙胺,在80~90℃下反应8~10h,分离纯化,得到4-(4-(1,3-二氧戊环-2-基)苯基)-2-甲基丁-3-炔-2-醇,反应方程式如下:Add p-bromobenzaldehyde, p-toluenesulfonic acid and ethylene glycol to chloroform, react at 50-70°C for 6-8 hours, evaporate the solvent under reduced pressure, and then add 2-methyl-3- Butyn-2-ol, cuprous iodide, triphenylphosphine, tetrakis (triphenylphosphine) palladium, triethylamine, react at 80~90℃ for 8~10h, separate and purify to obtain 4-(4- (1,3-dioxolane-2-yl)phenyl)-2-methylbut-3-yn-2-ol, the reaction equation is as follows: (2)制备2-(4-((4-(烷氧基)苯基)乙炔基)苯基)-1,3-二氧戊环(2) Preparation of 2-(4-((4-(alkoxy)phenyl)ethynyl)phenyl)-1,3-dioxolane 将4-(4-(1,3-二氧戊环-2-基)苯基)-2-甲基丁-3-炔-2-醇、式I所示1-碘-4-(烷氧基)苯、乙二醇乙醚、氢氧化钠、四(三苯基膦)钯加入甲苯中,在氮气保护下60~80℃反应8~10h,反应结束后,分离纯化,得到2-(4-((4-(烷氧基)苯基)乙炔基)苯基)-1,3-二氧戊环,反应方程式如下:4-(4-(1,3-dioxolan-2-yl)phenyl)-2-methylbut-3-yn-2-ol, 1-iodo-4-(alkane shown in formula I Oxy)benzene, ethylene glycol ether, sodium hydroxide, and tetrakis(triphenylphosphine)palladium were added to toluene, and reacted at 60-80 °C for 8-10 h under nitrogen protection. After the reaction was completed, separation and purification were performed to obtain 2-( 4-((4-(alkoxy)phenyl)ethynyl)phenyl)-1,3-dioxolane, the reaction equation is as follows: 式I中,R代表C5~C12的直链烷基;In formula I, R represents a C 5 -C 12 straight-chain alkyl group; (3)制备4-((4-(烷氧基)苯基)乙炔基)苯甲醛(3) Preparation of 4-((4-(alkoxy)phenyl)ethynyl)benzaldehyde 将2-(4-((4-(烷氧基)苯基)乙炔基)苯基)-1,3-二氧戊环、甲酸加入四氢呋喃中,在50~70℃下反应5~6h,反应结束后,分离纯化,得到4-((4-(烷氧基)苯基)乙炔基)苯甲醛,反应方程式如下:Add 2-(4-((4-(alkoxy)phenyl)ethynyl)phenyl)-1,3-dioxolane and formic acid to tetrahydrofuran, and react at 50~70℃ for 5~6h, After the reaction is finished, separation and purification are performed to obtain 4-((4-(alkoxy)phenyl)ethynyl)benzaldehyde, and the reaction equation is as follows: (4)制备2-((4-((4-(烷氧基)苯基)乙炔基)苯亚甲基)氨基)苯酚(4) Preparation of 2-((4-((4-(alkoxy)phenyl)ethynyl)benzylidene)amino)phenol 将4-((4-(烷氧基)苯基)乙炔基)苯甲醛、式II所示氨基酚加入乙醇中,搅拌回流4~6h,减压蒸馏除去溶剂,重结晶得到2-((4-((4-(烷氧基)苯基)乙炔基)苯亚甲基)氨基)苯酚,反应方程式如下:Add 4-((4-(alkoxy)phenyl)ethynyl)benzaldehyde and aminophenol shown in formula II to ethanol, stir and reflux for 4-6h, remove the solvent by vacuum distillation, and recrystallize to obtain 2-(( 4-((4-(alkoxy) phenyl) ethynyl) benzylidene) amino) phenol, reaction equation is as follows: 式II中,X代表H、CH3、NO2中任意一种;In formula II, X represents any one of H, CH 3 , and NO 2 ; (5)制备含炔键的苯并噁唑液晶化合物(5) Preparation of acetylene bond-containing benzoxazole liquid crystal compounds 将2-((4-((4-(烷氧基)苯基)乙炔基)苯亚甲基)氨基)苯酚、二氯二氰基苯醌加入三氯甲烷中,回流反应4~6h后,停止反应,分离纯化,得到含炔键的苯并噁唑液晶化合物。Add 2-((4-((4-(alkoxy)phenyl)ethynyl)benzylidene)amino)phenol and dichlorodicyanobenzoquinone into chloroform, and react under reflux for 4 to 6 hours. , stop the reaction, separate and purify, and obtain the benzoxazole liquid crystal compound containing alkyne bond. 3.根据权利要求2所述的含炔键的苯并噁唑液晶化合物的制备方法,其特征在于:步骤(1)中,所述对溴苯甲醛与对甲苯磺酸、乙二醇的摩尔比4:0.9~1.2:80~90,对溴苯甲醛与2-甲基-3-丁炔-2-醇、碘化亚铜、三苯基膦、四(三苯基膦)钯的摩尔比1:0.4~1:0.01~0.03:0.04~0.08:0.007~0.01。3. the preparation method of the acetylenic bond-containing benzoxazole liquid crystal compound according to claim 2, is characterized in that: in step (1), the mole of described p-bromobenzaldehyde and p-toluenesulfonic acid, ethylene glycol Ratio 4:0.9~1.2:80~90, moles of p-bromobenzaldehyde to 2-methyl-3-butyn-2-ol, cuprous iodide, triphenylphosphine, tetrakis(triphenylphosphine)palladium The ratio is 1:0.4~1:0.01~0.03:0.04~0.08:0.007~0.01. 4.根据权利要求2所述的含炔键的苯并噁唑液晶化合物的制备方法,其特征在于:步骤(2)中,所述4-(4-(1,3-二氧戊环-2-基)苯基)-2-甲基丁-3-炔-2-醇与1-碘-4-(烷氧基)苯、乙二醇乙醚、氢氧化钠、四(三苯基膦)钯的摩尔比1:1~1.2:10~15:5~8:0.02~0.05。4. The preparation method of the acetylenic bond-containing benzoxazole liquid crystal compound according to claim 2, characterized in that: in step (2), the 4-(4-(1,3-dioxolane- 2-yl)phenyl)-2-methylbut-3-yn-2-ol with 1-iodo-4-(alkoxy)benzene, ethylene glycol ether, sodium hydroxide, tetrakis(triphenylphosphine) ) The molar ratio of palladium is 1:1 to 1.2:10 to 15:5 to 8:0.02 to 0.05. 5.根据权利要求2所述的含炔键的苯并噁唑液晶化合物的制备方法,其特征在于:步骤(3)中,所述2-(4-((4-(烷氧基)苯基)乙炔基)苯基)-1,3-二氧戊环与甲酸的摩尔比为1:180~185。5. The preparation method of the acetylenic bond-containing benzoxazole liquid crystal compound according to claim 2, characterized in that: in step (3), the 2-(4-((4-(alkoxy)benzene The molar ratio of yl)ethynyl)phenyl)-1,3-dioxolane to formic acid is 1:180-185. 6.根据权利要求2所述的含炔键的苯并噁唑液晶化合物的制备方法,其特征在于:步骤(4)中,所述4-((4-(烷氧基)苯基)乙炔基)苯甲醛与氨基酚的摩尔比1:1.1~1.5。6 . The method for preparing an acetylenic bond-containing benzoxazole liquid crystal compound according to claim 2 , wherein: in step (4), the 4-((4-(alkoxy)phenyl)acetylene The molar ratio of benzaldehyde to aminophenol is 1:1.1~1.5. 7.根据权利要求2所述的含炔键的苯并噁唑液晶化合物的制备方法,其特征在于:步骤(5)中,所述2-((4-((4-(烷氧基)苯基)乙炔基)苯亚甲基)氨基)苯酚与二氯二氰基苯醌的摩尔比为1:1.1~1.5。7. The preparation method of the acetylenic bond-containing benzoxazole liquid crystal compound according to claim 2, wherein in step (5), the 2-((4-((4-(alkoxy) The molar ratio of phenyl)ethynyl)benzylidene)amino)phenol to dichlorodicyanobenzoquinone is 1:1.1-1.5.
CN201910813705.8A 2019-08-30 2019-08-30 benzoxazole liquid crystal compound containing acetylene bonds and preparation method thereof Pending CN110551076A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910813705.8A CN110551076A (en) 2019-08-30 2019-08-30 benzoxazole liquid crystal compound containing acetylene bonds and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910813705.8A CN110551076A (en) 2019-08-30 2019-08-30 benzoxazole liquid crystal compound containing acetylene bonds and preparation method thereof

Publications (1)

Publication Number Publication Date
CN110551076A true CN110551076A (en) 2019-12-10

Family

ID=68738561

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910813705.8A Pending CN110551076A (en) 2019-08-30 2019-08-30 benzoxazole liquid crystal compound containing acetylene bonds and preparation method thereof

Country Status (1)

Country Link
CN (1) CN110551076A (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0446162A (en) * 1990-06-08 1992-02-17 Canon Inc Liquid crystal compound, liquid crystal composition containing the compound and liquid crystal element using the same
DE19809944A1 (en) * 1997-03-27 1998-10-01 Merck Patent Gmbh Electroluminescent liquid crystal device
CN1504464A (en) * 2002-11-29 2004-06-16 石家庄实力克液晶材料有限公司 2,5-substituted benzoxazole derivative, preparing process and uses thereof
US20050056811A1 (en) * 2003-07-17 2005-03-17 Fuji Photo Film Co., Ltd. Liquid crystalline compound, liquid crystalline composition and retardation film
CN103304506A (en) * 2013-06-07 2013-09-18 陕西师范大学 Method for preparing fluorine-containing benzoxazole liquid crystal compound

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0446162A (en) * 1990-06-08 1992-02-17 Canon Inc Liquid crystal compound, liquid crystal composition containing the compound and liquid crystal element using the same
DE19809944A1 (en) * 1997-03-27 1998-10-01 Merck Patent Gmbh Electroluminescent liquid crystal device
CN1504464A (en) * 2002-11-29 2004-06-16 石家庄实力克液晶材料有限公司 2,5-substituted benzoxazole derivative, preparing process and uses thereof
US20050056811A1 (en) * 2003-07-17 2005-03-17 Fuji Photo Film Co., Ltd. Liquid crystalline compound, liquid crystalline composition and retardation film
CN103304506A (en) * 2013-06-07 2013-09-18 陕西师范大学 Method for preparing fluorine-containing benzoxazole liquid crystal compound

Non-Patent Citations (11)

* Cited by examiner, † Cited by third party
Title
EIJI SHIRAKAWA ET AL.: "A simple catalyst system for the palladium-catalyzed coupling of aryl halides with terminal alkynes", 《TETRAHEDRON》 *
EIJI SHIRAKAWA ET AL.: "A simple catalyst system for the palladium-catalyzed coupling of aryl halides with terminal alkynes", 《TETRAHEDRON》, vol. 61, 31 December 2005 (2005-12-31), pages 9881 *
GUOQING LIU ET AL.: "Synthesis and properties of benzoxazole-based liquid crystals containing ethynyl group", 《LIQUID CRYSTALS》 *
GUOQING LIU ET AL.: "Synthesis and properties of benzoxazole-based liquid crystals containing ethynyl group", 《LIQUID CRYSTALS》, vol. 47, no. 12, 31 December 2020 (2020-12-31), pages 1719 - 1728 *
JIBA RAJ ACHARYA,ET AL.: "Chemically Controlled Amplified Ratiometric Fluorescence in Surface-Immobilized End-Capped Oligo(p-phenylene ethynylene)s", 《J. AM. CHEM. SOC.》, vol. 131, 2 January 2009 (2009-01-02), pages 8 - 10 *
RAN CHEN ET AL.: "Synthesis and properties of allyloxy-based tolane liquid crystals with high negative dielectric anisotropy", pages 4 - 6 *
ROMAN DĄBROWSKI ET AL.: "High Birefringence Liquid Crystals", vol. 3, pages 443 - 482, XP002753151, DOI: 10.3390/cryst3030443 *
包建文编著: "《耐高温树脂基复合材料及其应用》", vol. 1, 31 December 2018, 航空工业出版社, pages: 41 *
施丁倩: "向列相型侧氟苯并噁唑类液晶的制备与性能", 《中国优秀博硕士学位论文全文数据库(硕士) 工程科技I辑》, no. 04, 15 April 2017 (2017-04-15), pages 3 - 2 *
施丁倩: "向列相型侧氟苯并噁唑类液晶的制备与性能", pages 52 *
莫玲超等: "侧向多氟取代二芳基乙炔类液晶的合成及性能", vol. 30, no. 8, pages 861 - 866 *

Similar Documents

Publication Publication Date Title
CN103304506B (en) Method for preparing fluorine-containing benzoxazole liquid crystal compound
US9493704B2 (en) Cycloheptane derivative and preparation method and use thereof
CN102153454B (en) A liquid crystal compound substituted by superfluorine and containing CF2O bridge bonds, its synthesis method and application
JP5604809B2 (en) Fluorobenzene derivative and liquid crystal composition containing the compound
CN109423297B (en) Dibenzothiophene liquid crystal compound and preparation method and application thereof
KR101210461B1 (en) Trifluoronaphthalene derivative and liquid crystal composition containing the compound
JP4691893B2 (en) Liquid crystal composition, display element and compound containing trifluoronaphthalene derivative.
CN102827614A (en) Negative liquid crystal containing 2, 3, 5, 6-tetra-fluorine phenylene, as well as synthesis method and application of negative liquid crystal
JP5526686B2 (en) Difluorobenzene derivatives and liquid crystal compositions containing the same.
CN110437846B (en) Fluorine substituted benzoxazole liquid crystal compound containing acetylene bond and preparation method thereof
JP5493596B2 (en) Difluorobenzene derivatives and liquid crystal compositions containing the same.
CN103333697B (en) Nematic negative liquid crystal containing 2,3,5,6-tetrafluorotolane, synthetic method and application
CN102585838A (en) A kind of 4-[(4-R alkoxy 2,3,5,6-tetrafluorophenyl) ethyl] benzoic acid (4-R1 alkoxy) phenyl ester fluorine-containing liquid crystal compound
CN110650948A (en) Liquid crystal compound and composition thereof
CN101880219B (en) A kind of liquid crystal compound and preparation method thereof
CN110551076A (en) benzoxazole liquid crystal compound containing acetylene bonds and preparation method thereof
JP2013001683A (en) Liquid crystal compound having 2,6,7-trioxa-bicyclo[2.2.2]octane skeleton and liquid crystal composition
CN102617303B (en) Multi-fluorine substituted bi-(phenyl acetenyl) benzene derivative, preparation method thereof and application
JP5545517B2 (en) Tetracyclic azine compound
CN108165278A (en) A kind of tolans butene-based liquid crystal compounds and its synthetic method
CN110483434A (en) Big birefringence side fluorine benzoxazoles liquid-crystal compounds containing acetylene bond and preparation method thereof
CN107699253A (en) Super fluorine negative liquid crystal compound and constituent, the preparation and application in liquid crystal display device
CN110483409A (en) N- methyl substituted benzimidazole class fluorinated liquid crystal compound and preparation method thereof
CN110483408A (en) A kind of N- methyl substituted benzimidazole side fluorine liquid-crystal compounds of big birefringence and preparation method thereof
CN116023950B (en) Liquid crystal compound and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20191210

WD01 Invention patent application deemed withdrawn after publication